Simple nausea prevention for germ cell cancer chemo
Treatments studied
Part of Cancer clinical trials.
This trial tests a simplified medication routine using netupitant/palonosetron to prevent nausea and vomiting in patients with germ cell cancer who are receiving a 5-day cisplatin-based chemotherapy treatment as outpatients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with germ cell cancer.
- Your doctor has prescribed a 5-day chemotherapy regimen that includes cisplatin.
- Your treatment will be given on an outpatient basis (you won't stay overnight in the hospital).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether palonosetron helps prevent nausea and vomiting caused by chemotherapy that has a moderate risk of vomiting. It may help you feel more comfortable during chemo and avoid treatment interruptions from severe nausea.
This study tests if two medicines given together, fosaprepitant and palonosetron, can prevent nausea and vomiting caused by strong chemotherapy given over several days. It's for people who have never had chemo before and are about to start a multi-day treatment for a solid tumor.
This trial tests two anti-nausea medications, Rolapitant and Palonosetron, to see how well they prevent nausea and vomiting in people with lung cancer who are receiving both chemotherapy and radiation. The study aims to help patients manage these side effects better during treatment.
This trial tests a new form of megestrol acetate to prevent nausea and vomiting caused by chemotherapy in people with advanced stomach cancer who haven't had chemo before. It's for those starting a specific chemo combo that includes a PD-1 inhibitor and CAPOX.
This trial tests if combining two anti-nausea drugs (olanzapine and palonosetron) can prevent vomiting and nausea without using steroids in people receiving high-dose cisplatin chemotherapy for their first time.
This study tests whether the medication NEPA (Netupitant and Palonosetron) can prevent nausea and vomiting in people who have had surgery for liver, gallbladder, or pancreatic cancer. It may help those who want to avoid post-surgery sickness.
Hear when a new Germ Cell Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.